Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Breast 1

Conditions

Gliosarcoma 4Glioblastoma 4Central Nervous System Neoplasms 4Astrocytoma 3Sarcoma 2Oligodendroglioma 2Neoplasm Metastasis 2Glioma, Subependymal 2Glioma 2Ependymoma 2Brain Neoplasms 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Recurrence 1Pheochromocytoma 1Osteosarcoma 1Optic Nerve Glioma 1Mesothelioma, Malignant 1Medulloblastoma 1Liver Neoplasms 1Head and Neck Neoplasms 1Familial ependymoma 1Desmoid Tumors 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adrenocortical Carcinoma 1Adenocarcinoma, Follicular 1

Interventions

Cyclophosphamide 39Peripheral Blood Stem Cell Transplantation 32fludarabine phosphate 30Busulfan 26Filgrastim 24Cyclosporine 24Mycophenolic Acid 22Antilymphocyte Serum 22Radiotherapy 20Melphalan 16Whole-Body Irradiation 15Tacrolimus 14Methylprednisolone 14Methotrexate 13Cord Blood Stem Cell Transplantation 12Etoposide 10sargramostim 5Thiotepa 5Temozolomide 5Sirolimus 5Rituximab 5Bevacizumab 5aldesleukin 4Therapeutics 4Granulocyte Colony-Stimulating Factor 4Cytarabine 4Carmustine 4pembrolizumab 3Vincristine 3Topotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Tamoxifen × Sarcoma × Clear all
NCT00001436 2008-03-04

A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
24 enrolled
Sarcoma

Neoplasm Metastasis, Recurrence, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡